QuadMedicine, Inc. (KOSDAQ:464490)
15,900
+1,790 (12.69%)
At close: Mar 5, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 182.57 billion as of March 6, 2026.
Market Cap
182.57B
Enterprise Value
185.66B
Revenue
13.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
15,900.00
Market Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 182.57B, a decrease of -8.69%. That is a compound annual growth rate of -32.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 182.57B | 3.25% |
| Dec 30, 2025 | 176.81B | -11.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ensol Biosciences | 182.35B |
| TiumBio | 183.78B |
| Genome & Company | 195.05B |
| Kangstem Biotech | 197.51B |
| CORESTEMCHEMON | 129.75B |
| Prestige Biologics | 206.43B |
| ISU Abxis | 207.67B |
| BIO-FD&C | 123.13B |